(LDOS) Leidos Holdings - Overview
Stock: Defense, Cybersecurity, Health, Aviation, Energy
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.02% |
| Yield on Cost 5y | 1.66% |
| Yield CAGR 5y | 3.88% |
| Payout Consistency | 85.9% |
| Payout Ratio | 14.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 26.4% |
| Relative Tail Risk | -24.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.12 |
| Alpha | 25.36 |
| Character TTM | |
|---|---|
| Beta | 0.501 |
| Beta Downside | 0.472 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.86% |
| CAGR/Max DD | 0.71 |
Description: LDOS Leidos Holdings December 17, 2025
Leidos Holdings, Inc. (NYSE:LDOS) delivers a broad portfolio of technology and engineering services to government and commercial clients, organized into four primary segments: National Security & Digital, Health & Civil, Commercial & International, and Defense Systems. The National Security & Digital segment leverages AI/ML to integrate sea, ground, air, and space operations, offering cyber-defense, intelligence analysis, biometrics, and digital transformation services. The Health & Civil segment supports air-traffic control, health-mission software, managed health services, and life-science R&D. The Commercial & International segment focuses on grid modernization, airport security platforms, biometric border solutions, and inspection technologies. The Defense Systems segment provides airborne, missile-defense, maritime, aerospace, and cyber-threat systems.
Key financial and market indicators underscore Leidos’ growth trajectory: FY 2023 revenue reached approximately $12.4 billion, with an operating margin of 9.5% and a backlog of roughly $8.5 billion, reflecting strong multi-year contract pipelines. Federal defense spending is projected to rise 3-4% YoY, bolstering demand for Leidos’ cyber-security and AI-driven warfighter solutions, while the U.S. Department of Transportation’s $30 billion air-traffic modernization plan fuels the Health & Civil segment’s pipeline.
Leidos’ diversification across high-growth government IT, defense, and critical infrastructure markets positions it to benefit from sustained fiscal-year spending increases and the broader digital-transformation wave in the public sector.
For a deeper quantitative dive, you might explore LDOS’s metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 1.41b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 0.35 > 1.0 |
| NWC/Revenue: 10.75% < 20% (prev 5.42%; Δ 5.32% < -1%) |
| CFO/TA 0.11 > 3% & CFO 1.55b > Net Income 1.41b |
| Net Debt (4.25b) to EBITDA (2.35b): 1.81 < 3 |
| Current Ratio: 1.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (130.1m) vs 12m ago -2.88% < -2% |
| Gross Margin: 17.61% > 18% (prev 0.17%; Δ 1745 % > 0.5%) |
| Asset Turnover: 129.0% > 50% (prev 122.0%; Δ 6.92% > 0%) |
| Interest Coverage Ratio: 10.18 > 6 (EBITDA TTM 2.35b / Interest Expense TTM 202.0m) |
Altman Z'' 3.51
| A: 0.14 (Total Current Assets 4.85b - Total Current Liabilities 2.99b) / Total Assets 13.54b |
| B: 0.32 (Retained Earnings 4.38b / Total Assets 13.54b) |
| C: 0.15 (EBIT TTM 2.06b / Avg Total Assets 13.44b) |
| D: 0.50 (Book Value of Equity 4.32b / Total Liabilities 8.59b) |
| Altman-Z'' Score: 3.51 = A |
Beneish M -3.03
| DSRI: 1.03 (Receivables 2.97b/2.71b, Revenue 17.33b/16.28b) |
| GMI: 0.94 (GM 17.61% / 16.59%) |
| AQI: 0.98 (AQ_t 0.53 / AQ_t-1 0.54) |
| SGI: 1.06 (Revenue 17.33b / 16.28b) |
| TATA: -0.01 (NI 1.41b - CFO 1.55b) / TA 13.54b) |
| Beneish M-Score: -3.03 (Cap -4..+1) = AA |
What is the price of LDOS shares?
Over the past week, the price has changed by -1.54%, over one month by +2.69%, over three months by -1.16% and over the past year by +33.76%.
Is LDOS a buy, sell or hold?
- StrongBuy: 8
- Buy: 2
- Hold: 7
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the LDOS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 219.3 | 16.5% |
| Analysts Target Price | 219.3 | 16.5% |
| ValueRay Target Price | 232.4 | 23.5% |
LDOS Fundamental Data Overview January 29, 2026
P/E Forward = 14.5773
P/S = 1.3853
P/B = 4.8743
P/EG = 2.34
Revenue TTM = 17.33b USD
EBIT TTM = 2.06b USD
EBITDA TTM = 2.35b USD
Long Term Debt = 4.63b USD (from longTermDebt, last quarter)
Short Term Debt = 19.0m USD (from shortTermDebt, last quarter)
Debt = 5.23b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.25b USD (from netDebt column, last quarter)
Enterprise Value = 28.27b USD (24.01b + Debt 5.23b - CCE 974.0m)
Interest Coverage Ratio = 10.18 (Ebit TTM 2.06b / Interest Expense TTM 202.0m)
EV/FCF = 20.39x (Enterprise Value 28.27b / FCF TTM 1.39b)
FCF Yield = 4.90% (FCF TTM 1.39b / Enterprise Value 28.27b)
FCF Margin = 8.00% (FCF TTM 1.39b / Revenue TTM 17.33b)
Net Margin = 8.11% (Net Income TTM 1.41b / Revenue TTM 17.33b)
Gross Margin = 17.61% ((Revenue TTM 17.33b - Cost of Revenue TTM 14.28b) / Revenue TTM)
Gross Margin QoQ = 18.37% (prev 18.39%)
Tobins Q-Ratio = 2.09 (Enterprise Value 28.27b / Total Assets 13.54b)
Interest Expense / Debt = 0.98% (Interest Expense 51.0m / Debt 5.23b)
Taxrate = 23.76% (115.0m / 484.0m)
NOPAT = 1.57b (EBIT 2.06b * (1 - 23.76%))
Current Ratio = 1.62 (Total Current Assets 4.85b / Total Current Liabilities 2.99b)
Debt / Equity = 1.07 (Debt 5.23b / totalStockholderEquity, last quarter 4.91b)
Debt / EBITDA = 1.81 (Net Debt 4.25b / EBITDA 2.35b)
Debt / FCF = 3.07 (Net Debt 4.25b / FCF TTM 1.39b)
Total Stockholder Equity = 4.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.45% (Net Income 1.41b / Total Assets 13.54b)
RoE = 30.81% (Net Income TTM 1.41b / Total Stockholder Equity 4.56b)
RoCE = 22.38% (EBIT 2.06b / Capital Employed (Equity 4.56b + L.T.Debt 4.63b))
RoIC = 16.60% (NOPAT 1.57b / Invested Capital 9.45b)
WACC = 6.51% (E(24.01b)/V(29.24b) * Re(7.76%) + D(5.23b)/V(29.24b) * Rd(0.98%) * (1-Tc(0.24)))
Discount Rate = 7.76% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.89%
[DCF Debug] Terminal Value 84.65% ; FCFF base≈1.36b ; Y1≈1.46b ; Y5≈1.79b
Fair Price DCF = 310.7 (EV 43.97b - Net Debt 4.25b = Equity 39.72b / Shares 127.9m; r=6.51% [WACC]; 5y FCF grow 8.43% → 2.90% )
EPS Correlation: 9.71 | EPS CAGR: -44.11% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.52 | Revenue CAGR: 6.81% | SUE: 2.92 | # QB: 1
EPS next Quarter (2026-03-31): EPS=2.96 | Chg30d=-0.035 | Revisions Net=-2 | Analysts=11
EPS next Year (2026-12-31): EPS=12.29 | Chg30d=-0.022 | Revisions Net=+0 | Growth EPS=+4.0% | Growth Revenue=+3.7%